Lanreotide Peptides CAS 108736-35-2

99% Lanreotide Peptides Muscle Fitness with Best Quality

Basic Info
Production Capacity:1500kg/Month
Payment Terms:T/T, Western Union, Money Gram, Bitcoin
Model NO.: 108736-35-2
Customized: Non-Customized
Suitable for: Elderly, Adult
Purity: >99%
Market: Worldwide
Trademark: WUMEITECH
Specification: 100ml 200ml 500ml
HS Code: 3002200000
Powder: Yes
Certification: ISO 9001
State: Solid
Sample: Free
Usage: Increasing Lean Mass Gains & Weight Loss
Transport Package: 1kg/Plastic Bottle or as Required
Origin: Made-in-China
99% Lanreotide Peptides Muscle Fitness with Best Quality

Product Description
Important Notification: All of our products and services listed in this website are for research or production use only, not for direct human use.
Raw powder Lanreotide 108736-35-2

Synonyms: LANREOTIDE;AUTOGEL;BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE;BIM-23014;ANGIOPEPTIN;H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2;H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2, (DISULFIDE BOND);IPSTYL
MF: C54H69N11O10S2
MW: 1096.32
CAS:108736-35-2
Assay:98%
Appearance:white to off-white lyophilised powder

Packing:plastic vial (dedicated for peptide packing) or glass vial, quantity according to customer’s detail requirement.
Storage:a cool(2~8 degree C) & dry place protected from light, keep package close when not in use.

Lanreotide——-Pharmacology

Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, although with higher affinity to peripheral receptors, and has similar activity. However, while somatostatin is quickly broken down in the body (within minutes), lanreotide has a much longer half-life, and produces far more prolonged effects.The efficacy of lanreotide has not been extensively studied, and results differ greatly between trials and formulations.

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2.

Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for sale in the United States by the Food and Drug Administration (FDA) on August 30, 2007.

Lanreotide——-Indications

Lanreotide is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the management of symptoms caused by neuroendocrine tumors, particularly carcinoid tumors and VIPomas. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes.

Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.

Lanreotide ,In Dec 2014 the US FDA approved lanreotide for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Lanreotide——-Side effects

Lanreotide ,The main side effects of lanreotide treatment are mild to moderate pain at the injection site and gastrointestinal disturbances, such as diarrhea, nausea and vomiting. Isolated cases of gallstone formation have been associated with use of lanreotide, particularly over long periods of time.

How to use peptide ?

1.) Take an alcohol swab to the stopper of both your peptide vial and the vial of the dilutent.

With a 1cc syringe and draw your preferred dilutent. Choose an amount that will make measuring the final product simple.

1ml(cc) per 10mg vial of Melanotan would mean each 10 mark on a U100 slin syringe would equal 1mg of Melanotan

1ml(cc) per 10 IU vial would mean each 10 mark on a U100 slin syringe would equal 1 IU

2ml(cc) per 10mg vial of Melanotan would mean each 10 mark on a U100 slin syringe would equal 1mg of Melanotan

2ml(cc) added to a 10 IU vial would mean that the 20 mark on a U100 syringe would equal 1 IU

2.) Take the syringe with the dilutent and push it into the vial of lyophilized powder letting the dilutent dissolve the peptide.

3.) After all of the dilutent has been added to the vial, gentling swirl (do NOT agitate or violently shake the vial) until the lyophilized powder has dissolved and you are left with a clear liquid. The peptide is now ready for use. Store your now reconstituted peptide in the refrigerator.